Evaxion Biotech A/S (United States) is listed on the Nasdaq and has a market capitalization of $1.20 billion, with shareholders equity totaling $9.53 million.
The company employs approximately 35 people and operates in the Services sector, within the Commercial Services industry.
Over the past 12 months, Evaxion Biotech A/S reported $7.49 million in revenue, generating net income of $-12.29 million.
Key financial metrics include a P/E ratio of -97.31, a price-to-book (P/B) ratio of 125.47, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker EVAX.